Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 2Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Classical hematology 1

Conditions

Multiple Myeloma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Motor Activity 1Leukemia 1Fatigue 1Anemia 1

Interventions

Cyclophosphamide 18fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 11Antilymphocyte Serum 10fludarabine 9Exercise 9Busulfan 9Mycophenolic Acid 8Melphalan 8Dexamethasone 8Blood Specimen Collection 8Filgrastim 7Standard of Care 6Radiotherapy 6Behavior Therapy 6Acupuncture Therapy 6Therapeutics 5Specimen Handling 5Palliative Care 5Methotrexate 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Educational Status 5Surveys and Questionnaires 4Stem Cell Transplantation 4Psychiatric Rehabilitation 4Practice Guidelines as Topic 4Methylprednisolone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Multiple Myeloma × Epoetin Alfa × Clear all
NCT00400686 2018-02-22

Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma

The Cleveland Clinic

Phase NA Completed
31 enrolled 5 charts
Classical hematologyPlasma cell

Anemia, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00577096 2015-04-06

Effects of Exercise in Combination With Epoetin Alfa

University of Arkansas

Phase NA Completed
120 enrolled 16 charts
Plasma cell

Motor Activity, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡